Tessa Therapeutics Company

Tessa Therapeutics is a clinical stage biopharmaceutical company with the scientific vision of revolutionizing the treatment of cancer by redirecting the body’s potent anti-viral immune response to recognize and kill cancer cells. Tessa’s core virus-specific T cell (VST) platform has shown compelling results in the treatment of solid tumors, and the company is building a portfolio of therapies addressing a wide range of tumors by combining the qualities of its T cell platform with complementary technologies.
Technology: Stem cells/regenerative
Industry: Personalized Medicine
Headquarters: Singapore, Central Region, Singapore
Founded Date: 2011
Employees Number: 101-250
Funding Status: Venture Round

Visit Website
Register and Claim Ownership